Loading…
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 5,674 other S bills in the 119th — cohort avg 32d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Filing registrants (7)
2026 · third_quarter · Health Issues
Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced in Senate
Bills with similar content found using semantic analysis.
Sources: Congress.gov
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R 1521 Dental and Optometric Care Access Act S. 1716, the Vision Lab Choice Act Vision Care and Vision Care Plan Related Issues
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
Dental and Optometric Care Access Act; Vision Lab Choice Act S 1716
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · third_quarter · Health Issues
Introduction to EssilorLuxottica; Med-tech innovations; Issues related to Myopia education; Labor, Health and Human Services appropriations; H.R.1521 - DOC Access Act; S.1716 - Vision Lab Choice Act.
Client expense: $300,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R 1521 Dental and Optometric Care Access Act S. 1716, the Vision Lab Choice Act Vision Care and Vision Care Plan Related Issues
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Issues related to providing E-delivery of documents for ERISA health and welfare benefit products; the Voluntary Excepted and Supplemental Benefits Protection Act (bill not yet introduced); H.R. 1521, Doc Access Act of 2025, all provisions; S.1716, Vision Lab Choice Act of 2025, all provisions.
Client expense: $370,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
HR 1521: (DOC Access Act of 2025) This bill will improve health care coverage under vision and dental plans. HR 2483: SUPPORT for Patients and Communities Reauthorization Act of 2025. This bill seeks to modify various grants, programs and activities that address substance use and misuse as well as modify provisions related to scheduling of controlled substances. The bill will also make a requirement that Medicaid programs cover medication-assisted treatments for individuals with substance use disorders permanent. S. 1716: Vision Lab Choice Act of 2025. This bill will improve coverage under vision plans.
Client expense: $1,090,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Monitor issues related to vision care plans, including H.R.1521 - DOC Access Act of 2025, and S.1716 - Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Dental and Optometric Care Access Act; Vision Lab Choice Act S 1716
Client expense: Not reported · Firm income: $50,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · second_quarter · Health Issues
Introduction to EssilorLuxottica; Med-tech innovations; Issues related to Myopia education; Labor, Health and Human Services appropriations; Tariffs; US-Mexico-Canada Trade Agreement; H.R.1521 - DOC Access Act; S.1716 - Vision Lab Choice Act.
Client expense: $180,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
H.R 1521 Dental and Optometric Care Access Act S. 1716, the Vision Lab Choice Act Vision Care and Vision Care Plan Related Issues
Client expense: $110,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
HR 1521: (DOC Access Act of 2025) This bill will improve health care coverage under vision and dental plans. HR 2483: SUPPORT for Patients and Communities Reauthorization Act of 2025. This bill seeks to modify various grants, programs and activities that address substance use and misuse as well as modify provisions related to scheduling of controlled substances. The bill will also make a requirement that Medicaid programs cover medication-assisted treatments for individuals with substance use disorders permanent. S. 1716: Vision Lab Choice Act of 2025. This bill will improve coverage under vision plans.
Client expense: $719,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2026 · first_quarter · Health Issues
Introduction to EssilorLuxottica; Med-tech innovations; VA Pilot; Issues related to Myopia education; Government Accountability Office Report; Tariffs; US-Mexico-Canada Trade Agreement; H.R.1521 - DOC Access Act; S.1716 - Vision Lab Choice Act.
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Homeland Security, Dept of (DHS), SENATE
2025 · fourth_quarter · Health Issues
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R 1521 Dental and Optometric Care Access Act S. 1716, the Vision Lab Choice Act Vision Care and Vision Care Plan Related Issues
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Health Issues
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on consumer choice and competition in the vision market.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Health Issues
HR 1521: (DOC Access Act of 2025) This bill will improve health care coverage under vision and dental plans. HR 2483: SUPPORT for Patients and Communities Reauthorization Act of 2025. This bill seeks to modify various grants, programs and activities that address substance use and misuse as well as modify provisions related to scheduling of controlled substances. The bill will also make a requirement that Medicaid programs cover medication-assisted treatments for individuals with substance use disorders permanent. S. 1716: Vision Lab Choice Act of 2025. This bill will improve coverage under vision plans.
Client expense: $1,260,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · fourth_quarter · Health Issues
Introduction to EssilorLuxottica; Med-tech innovations; VA Pilot; H.R. 2853 / S. 1404, Combating Organized Retail Crime Act; Issues related to Myopia education; Tariffs; H.R. 1521, DOC Access Act; S. 1716, Vision Lab Choice Act.
Client expense: $150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Intl Trade Administration (ITA), SENATE
2025 · third_quarter · Health Issues
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R 1521 Dental and Optometric Care Access Act S. 1716, the Vision Lab Choice Act Vision Care and Vision Care Plan Related Issues
Client expense: $120,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Health Issues
HR 1521: (DOC Access Act of 2025) This bill will improve health care coverage under vision and dental plans. HR 2483: SUPPORT for Patients and Communities Reauthorization Act of 2025. This bill seeks to modify various grants, programs and activities that address substance use and misuse as well as modify provisions related to scheduling of controlled substances. The bill will also make a requirement that Medicaid programs cover medication-assisted treatments for individuals with substance use disorders permanent. S. 1716: Vision Lab Choice Act of 2025. This bill will improve coverage under vision plans.
Client expense: $750,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Health Issues
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on the vision care market.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · third_quarter · Health Issues
Introduction to EssilorLuxottica; Med-tech innovations; VA Pilot; H.R. 2853 / S. 1404, Combating Organized Retail Crime Act; Issues related to Myopia education; Tariffs; H.R. 1521, DOC Access Act; S. 1716, Vision Lab Choice Act.
Client expense: $130,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Health Issues
H.R. 1521, DOC Access Act of 2025 S. 1716, Vision Lab Choice Act
Client expense: Not reported · Firm income: $20,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
H.R 1521 Dental and Optometric Care Access Act S. 1716, the Vision Lab Choice Act Vision Care Related Issues
Client expense: $100,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2025 · second_quarter · Health Issues
Monitor issues related to vision care plans, including H.R.1521, the DOC Access Act of 2025, and S.1716, the Vision Lab Choice Act of 2025. Educate policymakers on the vision care market.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Republican |
| IA |
| Cindy Hyde-Smith | Republican | MS |
| Cynthia M. Lummis | Republican | WY |
| Elizabeth Warren | Democratic | MA |
| Jeanne Shaheen | Democratic | NH |
| Jeff Merkley | Democratic | OR |
| Jim Banks | Republican | IN |
| John Boozman | Republican | AR |
| John Hoeven | Republican | ND |
| Kirsten E. Gillibrand | Democratic | NY |
| Margaret Wood Hassan | Democratic | NH |
| Markwayne Mullin | Republican | OK |
| Marsha Blackburn | Republican | TN |
| Peter Welch | Democratic | VT |
| Richard Blumenthal | Democratic | CT |
| Roger Marshall | Republican | KS |
| Shelley Moore Capito | Republican | WV |
| Tammy Duckworth | Democratic | IL |
| Ted Budd | Republican | NC |
| Thom Tillis | Republican | NC |
| Tim Kaine | Democratic | VA |